UROGEN PHARMA LTD
URGN·M96088105·US·Common Stock·Healthcare - Biotechnology-Activist
URGN (UROGEN PHARMA LTD) is held by 98 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($81.7M), BlackRock, Inc. ($51.2M), TORONTO DOMINION BANK ($47M). Net institutional sentiment: Mixed.
98
Holders
Avg rating(21 Elite)
$496M
Total Value
50% (112)
Fund Consensus
48 buying - 48 selling
Who's Trading
InsiderSMSchoenberg MarkSell $400KJul 9, 2026
InsiderSMSchoenberg MarkSell $350KJun 22, 2026
InsiderSMSchoenberg MarkSell $143KJun 8, 2026
ActivistPBParadigm BioCapital Advisors LP3.5%May 15, 2026
InsiderSMSchoenberg MarkSell $300KMay 8, 2026
InsiderSMSchoenberg MarkSell $250KNov 19, 2025
ActivistCFCowen Financial Products LLC0.0%Nov 14, 2025
InsiderDCDegnan ChrisSell $37KOct 8, 2025
13F: Insider & Congress:
Showing 1-20 of 112
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer